U.S. flag

An official website of the United States government

Format
Items per page

Send to:

Choose Destination

Search results

Items: 7

1.

Lathosterolosis

Lathosterolosis (LATHOS) is an autosomal recessive disorder characterized by a recognizable pattern of multiple congenital anomalies involving axial and appendicular skeleton, liver, central nervous and urogenital systems, and lysosomal storage. It is caused by a defect of cholesterol biosynthesis due to sterol C5-desaturase deficiency (summary by Rossi et al., 2007). [from OMIM]

MedGen UID:
375885
Concept ID:
C1846421
Disease or Syndrome
2.

Dehydrated hereditary stomatocytosis 2

In dehydrated hereditary stomatocytosis (DHS), also known as hereditary xerocytosis, red blood cells exhibit altered intracellular cation content and cellular dehydration, resulting in increased erythrocyte mean corpuscular hemoglobin concentration (MCHC) and decreased erythrocyte osmotic fragility. Blood films show various cell shape abnormalities, the most characteristic being the stomatocyte, with a straight or crescent-shaped central pallor (summary by Rapetti-Mauss et al., 2015). For discussion of clinical and genetic heterogeneity of the stomatocytoses, see DHS1 (194380). [from OMIM]

MedGen UID:
908701
Concept ID:
C4225242
Disease or Syndrome
3.

Rothmund-Thomson syndrome, type 3

Rothmund-Thomson syndrome type 3 (RTS3) is characterized by poikiloderma, sparse hair, short stature, and skeletal defects. Patients also exhibit microcephaly, with moderate to severe neurodevelopmental delay and seizures (Averdunk et al., 2023). For a general phenotypic description and discussion of genetic heterogeneity of Rothmund-Thomson syndrome, see RTS2 (268400). [from OMIM]

MedGen UID:
862776
Concept ID:
C4014339
Disease or Syndrome
4.

Developmental and epileptic encephalopathy, 50

Developmental and epileptic encephalopathy-50 (DEE50) is an autosomal recessive progressive neurodegenerative neurometabolic disorder characterized by delayed psychomotor development, early-onset refractory seizures, severe developmental regression, and normocytic anemia. Onset is within the first months or years of life. Evidence suggests that affected children can have a favorable response to treatment with uridine (summary by Koch et al., 2017). For a discussion of genetic heterogeneity of DEE, see 308350. [from OMIM]

MedGen UID:
904125
Concept ID:
C4225320
Disease or Syndrome
5.

Thrombocytopenia, anemia, and myelofibrosis

MedGen UID:
1378448
Concept ID:
C4479504
Disease or Syndrome
6.

3-methylglutaconic aciduria, type VIIA

3-Methylglutaconic aciduria (MGCA7) is an inborn error of metabolism characterized primarily by increased levels of 3-methylglutaconic acid (3-MGA) associated with variable neurologic deficits and neutropenia. The phenotype is highly variable: most patients have infantile onset of a severe progressive encephalopathy with various movement abnormalities and delayed psychomotor development. Other common variable features include seizures, recurrent infections due to neutropenia, anemia, and brain imaging abnormalities (Wortmann et al., 2021). For a general phenotypic description and a discussion of genetic heterogeneity of 3-methylglutaconic aciduria, see MGCA1 (250950). [from OMIM]

MedGen UID:
1813022
Concept ID:
C5676967
Disease or Syndrome
7.

Anisopoikilocytosis

A type of poikilocytosis characterized by the presence in the blood of erythrocytes of varying sizes and abnormal shapes. [from HPO]

MedGen UID:
436556
Concept ID:
C2675920
Finding
Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Search details

See more...

Recent activity